CID 44626120

Edasalonexent

Structural Information

Molecular Formula
C31H42N2O3
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)C1=CC=CC=C1O
InChI
InChI=1S/C31H42N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25-30(35)32-26-27-33-31(36)28-23-21-22-24-29(28)34/h3-4,6-7,9-10,12-13,15-16,18-19,21-24,34H,2,5,8,11,14,17,20,25-27H2,1H3,(H,32,35)(H,33,36)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-
InChIKey
JQLBBYLGWHUHRW-KUBAVDMBSA-N
Compound name
N-[2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]ethyl]-2-hydroxybenzamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

6
References

219
Patents

490.31955 Da
Monoisotopic Mass

7.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 491.32683 231.6
[M+Na]+ 513.30877 236.4
[M+NH4]+ 508.35337 226.8
[M+K]+ 529.28271 227.1
[M-H]- 489.31227 229.9
[M+Na-2H]- 511.29422 230.1
[M]+ 490.31900 230.9
[M]- 490.32010 230.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe